http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0127389-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 1984-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1988-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1988-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0127389-B1 |
| titleOfInvention | N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor |
| abstract | There is disclosed, for use as an antitumour agent, the compound N,N-diethyl-5-methyl-2H-1- benzothiopyrano-[4,3,2-cd]-indazole-2- ethanamine as the free base or as a pharmaceutically acceptable acid addition salt. Pharmaceutical compositions comprising the same are also disclosed. The compositions are also useful for treating tumours in warm blooded animals. |
| priorityDate | 1983-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.